Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page history shows a new revision label, updating from v3.6.2 to v3.6.3, reflecting an update to the page's metadata. This is a UI/system update rather than any changes to trial details.
    Difference
    0.1%
    Check dated 2026-07-03T23:40:13.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study record history shows a new revision label 'Revision: v3.6.2' added, replacing the older 'Revision: v3.6.0'. This indicates a site update to the page rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-06-26T23:59:20.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A recruitment status change indicates no longer looking for participants. The record version has been updated to v3.6.0, replacing the prior v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-12T16:38:58.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a version update of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-06-05T11:34:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), updating the version sequence in the history.
    Difference
    0.1%
    Check dated 2026-05-15T05:40:55.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s platform revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a general software release with no apparent change to the displayed clinical trial record details.
    Difference
    0.1%
    Check dated 2026-04-23T22:08:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.